ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,042,000 | -13.0% | 50,000 | 0.0% | 0.59% | -11.0% |
| Q2 2023 | $1,197,500 | +27.3% | 50,000 | 0.0% | 0.66% | +2.3% |
| Q1 2023 | $941,000 | +18.2% | 50,000 | 0.0% | 0.65% | -17.4% |
| Q4 2022 | $796,000 | -33.8% | 50,000 | -2.9% | 0.79% | +124.6% |
| Q4 2021 | $1,202,000 | -1.6% | 51,500 | -29.9% | 0.35% | +12.9% |
| Q3 2021 | $1,221,000 | +271.1% | 73,500 | +444.4% | 0.31% | +248.3% |
| Q2 2021 | $329,000 | +161.1% | 13,500 | +474.5% | 0.09% | +67.9% |
| Q4 2020 | $126,000 | -3.1% | 2,350 | -25.4% | 0.05% | -15.9% |
| Q3 2020 | $130,000 | – | 3,150 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |